107.4K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 100,500 | 100,500 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 50,250 | 80,074 | - | 0 | Common Stock | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 145,250 | 246,380 | - | 0 | Common Stock | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 290,500 | 290,500 | - | - | Stock Option (right to buy) | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 93,000 | 93,000 | - | - | Stock Option (right to buy) | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 46,500 | 79,170 | - | 0 | Common Stock | |
| Joshua M. Eizen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 58,500 | 175,172 | - | 0 | Common Stock | |
| Joshua M. Eizen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 117,000 | 117,000 | - | - | Stock Option (right to buy) | |
| Stephen David Prior | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 28,000 | 61,313 | - | 0 | Common Stock | |
| Stephen David Prior | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 56,000 | 56,000 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 03 Jan 2025 | 2,957 | 29,824 | - | 1.3 | 3,965 | Common Stock |
| Lucy O. Day | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 03 Jan 2025 | 2,957 | 32,670 | - | 1.3 | 3,965 | Common Stock |
| Joshua M. Eizen | See Remarks | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 03 Jan 2025 | 9,663 | 116,672 | - | 1.3 | 12,958 | Common Stock |
| Stephen David Prior | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 03 Jan 2025 | 2,029 | 33,313 | - | 1.3 | 2,721 | Common Stock |
| Rob Readnour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 9,077 | 9,077 | - | 0 | Common Stock | |
| Joseph S. Zakrzewski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 9,816 | 135,015 | - | 0 | Common Stock | |
| Aziz Kabeer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 8,972 | 8,972 | - | 0 | Common Stock | |
| Lynn Marks Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 8,972 | 31,802 | - | 0 | Common Stock | |
| Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 3,166 | 3,166 | - | 0 | Common Stock | |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.44 per share. | 06 Dec 2024 | 12,711 | 564,999 | - | 1.4 | 18,367 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 06 Dec 2024 | 5,000 | 652,573 | - | 1.5 | 7,468 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 06 Dec 2024 | 5,000 | 582,288 | - | 1.5 | 7,462 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 06 Dec 2024 | 18,483 | 647,573 | - | 1.4 | 26,407 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 06 Dec 2024 | 12,289 | 577,288 | - | 1.4 | 17,577 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.45 per share. | 06 Dec 2024 | 6,517 | 629,090 | - | 1.4 | 9,427 | Common Stock |
| Joseph Zakrzewski S. | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 27 Nov 2024 | 2,000 | 125,199 | - | 1.4 | 2,800 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 26 Nov 2024 | 25,000 | 552,288 | - | 1.4 | 35,423 | Common Stock |
| Readnour Rob | Director | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 26 Nov 2024 | 12,500 | 527,288 | - | 1.4 | 17,418 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 26 Nov 2024 | 25,000 | 622,573 | - | 1.4 | 35,418 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 26 Nov 2024 | 12,500 | 597,573 | - | 1.4 | 17,428 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 19 Nov 2024 | 75,000 | 489,788 | - | 1.0 | 77,730 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 19 Nov 2024 | 25,000 | 514,788 | - | 1.2 | 28,870 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 19 Nov 2024 | 25,000 | 585,073 | - | 1.2 | 29,000 | Common Stock |
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 19 Nov 2024 | 75,000 | 560,073 | - | 1.0 | 77,528 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 18 Nov 2024 | 50,000 | 1,065,766 | - | 1.0 | 49,970 | Common Stock |
| Joseph S. Zakrzewski | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 18 Nov 2024 | 20,000 | 118,199 | - | 1.0 | 19,996 | Common Stock |
| Joseph S. Zakrzewski | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 18 Nov 2024 | 5,000 | 123,199 | - | 1.0 | 5,050 | Common Stock |
| Joshua M. Eizen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 31,500 | 126,335 | - | 0 | Common Stock | |
| Joshua M. Eizen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
| Stephen David Prior | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Stephen David Prior | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 10,125 | 35,342 | - | 0 | Common Stock | |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 60,000 | 94,833 | - | 0 | Common Stock | |
| Joseph S. Zakrzewski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Melvin K. Spigelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Stephanie Wong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Gilbert Lynn Marks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Rob Readnour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 27,500 | 28,235 | - | 0 | Common Stock | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 99,000 | 101,130 | - | 0 | Common Stock | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 198,000 | 198,000 | - | - | Stock Option (right to buy) | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 27,500 | 30,627 | - | 0 | Common Stock | |
| Paul Eckburg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Paul Eckburg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 51,416 | - | 0 | Common | |
| Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 31,914 | - | 0 | Common Stock | |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 32,447 | - | 0 | Common Stock | |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 27,500 | 28,235 | - | 0 | Common Stock | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 99,000 | 101,130 | - | 0 | Common Stock | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 27,500 | 30,627 | - | 0 | Common Stock | |
| Paul Eckburg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 51,416 | - | 0 | Common Stock | |
| Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 31,914 | - | 0 | Common Stock | |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 32,447 | - | 0 | Common Stock | |
| S. Joseph Zakrzewski | Director | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 18 Jan 2024 | 100,000 | 405,880 | - | 19.1 | 1,911,410 | Common Stock |
| Kabeer Aziz | Director | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 16 Jan 2024 | 15,907 | 377,542 | - | 19.7 | 312,573 | Common Stock |
| Aziz Kabeer | Director | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 16 Jan 2024 | 84,093 | 1,995,958 | - | 19.6 | 1,652,427 | Common Stock |
| Rob Readnour | Director | Sale of securities on an exchange or to another person at price $ 21.92 per share. | 12 Jan 2024 | 706 | 414,788 | - | 21.9 | 15,476 | Common Stock |
| Readnour Rob | Director | Sale of securities on an exchange or to another person at price $ 21.91 per share. | 12 Jan 2024 | 719 | 485,073 | - | 21.9 | 15,753 | Common Stock |
| Readnour Rob | Director | Sale of securities on an exchange or to another person at price $ 21.92 per share. | 10 Jan 2024 | 1,800 | 485,792 | - | 21.9 | 39,456 | Common Stock |
| Rob Readnour | Director | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 10 Jan 2024 | 1,869 | 415,494 | - | 21.9 | 40,987 | Common Stock |
| Krause Kevin | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,417 | 49,868 | - | - | Stock Option (right to buy) | |
| Kevin Krause | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 09 Jan 2024 | 2,417 | 4,331 | - | 0.4 | 1,015 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 09 Jan 2024 | 7,417 | 1,914 | - | 20.1 | 149,367 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.60 per share. | 09 Jan 2024 | 5,000 | 9,331 | - | 6.6 | 33,000 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 5,000 | 26,832 | - | - | Stock Option (right to buy) | |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.09 per share. | 02 Jan 2024 | 2,777 | 2,130 | - | 20.1 | 55,802 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 02 Jan 2024 | 2,583 | 4,497 | - | 0.4 | 1,085 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 02 Jan 2024 | 2,583 | 1,914 | - | 20.1 | 51,967 | Common Stock |
| Kevin Krause | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 2,583 | 52,285 | - | - | Stock Option (right to buy) | |
| Kabeer Aziz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Aug 2023 | 336 | 2,183,888 | - | 16 | 5,376 | Common Stock |
| Kabeer Aziz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Aug 2023 | 64 | 413,092 | - | 16 | 1,024 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 15 May 2023 | 10,000 | 1,015,766 | - | 5.4 | 53,770 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 267,650 | 267,650 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 57,950 | 57,950 | - | - | Stock Option (right to buy) | |
| Michael A. Nazak | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 16,600 | 16,600 | - | - | Stock Option (right to buy) | |
| Lucy O. Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 82,300 | 82,300 | - | - | Stock Option (right to buy) | |
| Paul Eckburg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 70,950 | 70,950 | - | - | Stock Option (right to buy) | |
| Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 62,200 | 62,200 | - | - | Stock Option (right to buy) | |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 50,150 | 50,150 | - | - | Stock Option (right to buy) | |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.32 per share. | 10 Nov 2022 | 4,413 | 4,930 | - | 15.3 | 67,628 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 10 Nov 2022 | 23 | 4,907 | - | 15.0 | 346 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.41 per share. | 08 Nov 2022 | 5,800 | 16,273 | - | 15.4 | 89,388 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.38 per share. | 08 Nov 2022 | 1,255 | 15,018 | - | 16.4 | 20,559 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 08 Nov 2022 | 10,111 | 4,907 | - | 15.6 | 157,847 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.90 per share. | 03 Nov 2022 | 10,167 | 6,943 | - | 15.9 | 161,705 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.80 per share. | 03 Nov 2022 | 8,828 | 17,110 | - | 15.8 | 139,474 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 03 Nov 2022 | 3,083 | 25,938 | - | 16.0 | 49,376 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 03 Nov 2022 | 11,082 | 29,021 | - | 15.7 | 173,683 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 03 Nov 2022 | 2,036 | 4,907 | - | 16.7 | 34,036 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 31 Oct 2022 | 1,544 | 4,907 | - | 15.1 | 23,263 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 31 Oct 2022 | 2,688 | 6,451 | - | 15.4 | 41,363 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.69 per share. | 24 Oct 2022 | 4,272 | 7,119 | - | 15.7 | 67,020 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 24 Oct 2022 | 2,866 | 11,391 | - | 16.2 | 46,344 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 24 Oct 2022 | 1,678 | 4,907 | - | 15.1 | 25,342 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.20 per share. | 24 Oct 2022 | 534 | 6,585 | - | 16.2 | 8,652 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.16 per share. | 20 Oct 2022 | 31 | 18,858 | - | 17.2 | 532 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.68 per share. | 20 Oct 2022 | 7,262 | 18,889 | - | 16.7 | 121,140 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.69 per share. | 20 Oct 2022 | 2,350 | 4,907 | - | 16.7 | 39,232 | Common Stock |
| Eric Easom | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.29 per share. | 20 Oct 2022 | 11,601 | 7,257 | - | 16.3 | 189,008 | Common Stock |
| Joshua M. Eizen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 92,000 | 92,000 | - | - | Stock Option (right to buy) | |
| Kabeer Aziz | Director, Ten Percent Owner | Other type of transaction at price $ 15.00 per share. | 06 Jun 2022 | 26,511 | 413,156 | - | 15 | 397,665 | Common Stock |
| Kabeer Aziz | Director, Ten Percent Owner | Other type of transaction at price $ 15.00 per share. | 06 Jun 2022 | 26,511 | 2,184,224 | - | 15 | 397,665 | Common Stock |
| Joseph S. Zakrzewski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Melvin K. Spigelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Stephanie Wong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Sanjay Chanda | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 66,000 | 66,000 | - | - | Stock Option (right to buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Eric Easom | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Lucy Day | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 66,000 | 66,000 | - | - | Stock Option (right to buy) | |
| Paul Eckburg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 66,000 | 66,000 | - | - | Stock Option (right to buy) | |
| Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 66,000 | 66,000 | - | - | Stock Option (right to buy) | |
| Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 20,724 | 20,724 | - | - | Stock Option (right to buy) | |
| Gilbert Lynn Marks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) | |
| Rob Readnour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 20,724 | 20,724 | - | - | Stock Option (right to buy) | |
| Margaret M. FitzPatrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 11,463 | 11,463 | - | - | Stock Option (right to buy) | |
| Joseph S. Zakrzewski | Director | 29 Mar 2022 | 98,199 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Joseph S. Zakrzewski | Director | 29 Mar 2022 | 98,199 | 98,199 | - | - | Common Stock | ||
| Eric Easom | Director, Chief Executive Officer | 29 Mar 2022 | 4,907 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Eric Easom | Director, Chief Executive Officer | 29 Mar 2022 | 4,907 | 4,907 | - | - | Common Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 392,433 | 2,044,069 | - | - | Common Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 1,651,636 | 1,651,636 | - | - | Common Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 312,415 | 312,415 | - | - | Common Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 74,230 | 386,645 | - | - | Common Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 29 Mar 2022 | 166,666 | 2,210,735 | - | 15 | 2,499,990 | Common Stock |
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 1,651,636 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 312,415 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 392,433 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 74,230 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 29 Mar 2022 | 82,618 | 487,592 | - | 15 | 1,239,270 | Common Stock |
| Rob Readnour | Director | 29 Mar 2022 | 285,156 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 333,135 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 61,491 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 71,839 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Rob Readnour | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 29 Mar 2022 | 70,716 | 417,363 | - | 15 | 1,060,740 | Common Stock |
| Rob Readnour | Director | 29 Mar 2022 | 71,839 | 404,974 | - | - | Common Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 61,491 | 346,647 | - | - | Common Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 333,135 | 333,135 | - | - | Common Stock | ||
| Rob Readnour | Director | 29 Mar 2022 | 285,156 | 285,156 | - | - | Common Stock |